Tag Archives: economies

Missouri Drought Alert 99% effected with 26% in an extreme state of drought

Missouri Drought Map 2023

Matthew 24:7 For nation will rise against nation, and kingdom against kingdom, and there will be famines and earthquakes in various places.

Important Takeaways:

  • A drought is a period of drier-than-normal conditions that results in water-related problems and other issues. When little or no rain falls, soils can dry out, plants can die and livestock can suffer. When dry weather persists, stream and river flows can decline, water levels in lakes and reservoirs can fall and water in wells and aquifers can decline. Drought can have a serious impact on health, agriculture, economies, energy and the environment.
  • Droughts can develop quickly or gradually over several weeks, months or even years, and worsened with extreme heat or wind. A drought can end just as quickly or gradually as it began, but more commonly persist for months. A single rainstorm may provide temporary relief, but its impact is short term. Thunderstorms often produce large amounts of rain in a very short time, causing the rain to run off into streams rather than soak into the ground. Several soaking rains may be required to recharge groundwater and break a drought.

Read the original article by clicking here.

Some scold, others cheerlead: U.S. states tackle reopening differently

By Maria Caspani and Jonathan Allen

NEW YORK (Reuters) – The two most populous U.S. states took markedly different approaches to reopening on Monday with New York scolding local governments for not enforcing social distancing and California encouraging counties to restart economies if they met criteria.

Scenes of merrymakers gathering outside bars prompted the governor of New York, the state hardest hit along with New Jersey by the coronavirus pandemic, to urge local officials and businesses on Monday to strictly enforce reopening guidelines.

“To the local governments I say, ‘Do your job,'” Governor Andrew Cuomo told reporters. Over the weekend he criticized New York City street crowds outside bars and asked people to adhere to six feet (two meters) of distance from others.

Both Cuomo and neighboring New Jersey Governor Phil Murphy said they were keeping open the option of reimposing restrictions if officials fail to stop large public gatherings that risk leading to a second wave of infections.

In California, Governor Gavin Newsom has left it up to individual counties on when to reopen once they meet state guidelines. He reminded county officials of the risks of not restarting economies, as well as reopening them.

Newsom told a news briefing on Monday people could not be “locked away for months and months and months,” especially those among the 5.5 million Americans who have lost their jobs since mid-March. He said some had also lost health coverage and were among the many people suffering severe mental and physical health problems during the pandemic.

In enforcing coronavirus restrictions, he said the state and counties could not “see lives and livelihoods completely destroyed without considering the health impact of those decisions as well.”

“As we mix, as we reopen, inevitably we’re going to see an increase in the total number of cases; it’s our capacity to address that that is so foundational,” said Newsom.

NEW FORECAST

California is one of four states that is projected to see the biggest spike in deaths in the months ahead, according to the Institute for Health Metrics and Evaluation (IHME) at the University of Washington.

Its new forecast on Monday forecast over 200,000 deaths due to COVID-19 in the United States through the beginning of October, mainly due to reopening measures underway.

The IHME, whose estimates are cited by many health experts, projected Florida will see its deaths nearly triple to 18,675 deaths from 6,559 on June 10, while California can expect to see deaths increase by 72 percent to 15,155 from 8,812, it said.

Georgia and Arizona also have sharp increases in deaths forecast by the institute.

New York and New Jersey between them account for more than a third of the nearly 116,000 U.S. deaths, but deaths and hospitalizations have been on the decline of late. Both have followed strict health guidelines for reopening businesses when all measures of infection drop – new cases, deaths, hospitalizations and positive rates among those getting tested.

Scott Gottlieb, the former Food and Drug Administration director who has advised the White House on the coronavirus, said on Monday that flare-ups needed to be addressed with aggressive contact tracing and targeted responses.

“We’re not going to be able to shut down the country again this summer. We’re probably not going to be able to shut down the country again this fall,” he said on CNBC.

(Reporting by Doina Chiacu in Washington, Jonathan Allen and Maria Caspani in New York, Lisa Shumaker in Chicago, Andrew Hay in Taos, New Mexico; Writing by Sonya Hepinstall and Andrew Hay; Editing by Howard Goller, Bill Tarrant and Cynthia Osterman)

U.S. secures 300 million doses of potential AstraZeneca COVID-19 vaccine

By Aakash B, Guy Faulconbridge and Kate Holton

BENGALURU/LONDON (Reuters) – The United States has secured almost a third of the first 1 billion doses planned for AstraZeneca’s experimental COVID-19 vaccine by pledging up to $1.2 billion, as world powers scramble for medicines to get their economies back to work.

While not yet proven to be effective against the coronavirus, vaccines are seen by world leaders as the only real way to restart their stalled economies, and even to get an edge over global competitors.

After President Donald Trump demanded a vaccine, the U.S. Department of Health and Human Services (HHS) agreed to provide up to $1.2 billion to accelerate British drugmaker AstraZeneca’s vaccine development and secure 300 million doses for the United States.

“This contract with AstraZeneca is a major milestone in Operation Warp Speed’s work toward a safe, effective, widely available vaccine by 2021,” U.S. Health Secretary Alex Azar said. The first doses could be available in the United States as early as October, according to a statement from HHS.

The vaccine, previously known as ChAdOx1 nCoV-19 and now as AZD1222, was developed by the University of Oxford and licensed to AstraZeneca. Immunity to the new coronavirus is uncertain and so the use of vaccines is unclear.

The U.S. deal allows a late-stage, or Phase III, clinical trial of the vaccine with 30,000 people in the United States.

Cambridge, England-based AstraZeneca said it had concluded agreements for at least 400 million doses of the vaccine and secured manufacturing capacity for 1 billion doses, with first deliveries due to begin in September.

Now the most valuable company on Britain’s blue-chip FTSE 100 Index, AstraZeneca has already agreed to deliver 100 million doses to people in Britain, with 30 million as soon as September. Ministers have promised Britain will get first access to the vaccine.

VACCINE SCRAMBLE

With leaders across the world surveying some of the worst economic destruction since at least World War Two and the deaths of more than 327,000 people, many are scrambling for a vaccine.

The U.S. government has struck deals to support vaccine development with Johnson & Johnson (J&J), Moderna and Sanofi, sparking fears the richest countries will be able to protect their citizens first.

Sanofi’s chief angered the French government earlier this month when he said vaccine doses produced in the United States could go to U.S. patients first, given the country had supported the research financially.

“We have a lot of things happening on the vaccine front or the therapeutic front,” Trump told reporters at the White House when asked about the AstraZeneca announcement. “You’re going to have a lot of big announcements over the next week or two” on therapeutics.

Trump, during a Thursday visit to a Ford Motor Co plant in Michigan, said the U.S. military is “in gear so we can give out 150 to 250 million shots quickly.”

AstraZeneca said it was in talks with governments and partners around the world – such as the Serum Institute of India – to increase access and production and is speaking to various organizations on fair allocation and distribution.

“We would like to thank the U.S. and UK governments for their substantial support to accelerate the development and production of the vaccine,” AstraZeneca Chief Executive Pascal Soriot said.

The Serum Institute of India, the world’s largest maker of vaccines by volume, has dedicated one of its facilities with a capacity to produce up to 400 million doses annually to producing the Oxford vaccine.

“We are scaling up on a conservative basis of about 4 to 5 million doses a month to begin with,” Chief Executive Adar Poonawalla told Reuters, adding the company was in discussions with AstraZeneca.

COVID-19 PROTECTION?

A Phase I/II clinical trial of AZD1222 began last month to assess safety, immunogenicity and efficacy in over 1,000 healthy volunteers aged 18 to 55 across several trial centers in southern England. Data from the trial is expected shortly.

There are currently no approved treatments or vaccines for COVID-19.

Governments, drugmakers and researchers are working on around 100 programs. Experts are predicting a safe, effective means of preventing the disease could take 12 to 18 months to develop.

Only a handful of the vaccines in development have advanced to human trials, an indicator of safety and efficacy, and the stage at which most fail.

“AstraZeneca recognizes that the vaccine may not work but is committed to progressing the clinical program with speed and scaling up manufacturing at risk,” it said.

Other drugmakers including Pfizer Inc, J&J and Sanofi are in various stages of vaccine development.

U.S.-based Inovio Pharmaceuticals said Wednesday its experimental vaccine produced protective antibodies and immune system responses in mice and guinea pigs.

And Moderna this week released positive data for its potential vaccine, which it said produced protective antibodies in a small group of healthy volunteers.

(Reporting by Aakash Jagadeesh Babu in Bengaluru, Ludwig Burger in Frankfurt and Zeba Siddiqui in New Delhi; writing by Guy Faulconbridge; editing by Alexander Smith, Jan Harvey, Mark Potter, Jonathan Oatis and Leslie Adler)

U.S. regains crown as most competitive economy for first time since 2008

FILE PHOTO: U.S. President Donald Trump gestures as he delivers a speech during the World Economic Forum (WEF) annual meeting in Davos, Switzerland January 26, 2018. REUTERS/Denis Balibouse/File Photo

By Katanga Johnson

WASHINGTON (Reuters) – The U.S. economy sits atop of the World Economic Forum’s annual global competitiveness survey for the first time since the 2007-2009 financial crisis, benefiting from a new ranking methodology this year, the Swiss body said on Tuesday.

In its closely-watched annual Global Competitiveness Report, the WEF said the U.S. is the country closest to the “frontier of competitiveness,” an indicator that ranks competitive productivity using a scale from zero to 100.

The U.S. beat off Singapore, Germany, Switzerland and Japan, the other top four markets, with a score of 85.6 out of 100, the report said, due to its “vibrant” entrepreneurial culture and “strong” labor market and financial system.

The World Economic Forum, the same organization that runs the Davos meeting of global powerbrokers each January, bases its rankings of 140 economies on a dozen drivers of competitiveness, including a country’s institutions and the policies that help drive productivity.

This year the WEF changed its methodology to better account for future readiness for competition, such as a country’s idea generation, entrepreneurial culture, and the number of businesses that disrupt existing markets.

The last time the U.S. topped the list was 2008.

The WEF said it was too early to factor in how the Trump administration’s recent trade policies would affect its ranking.

“While it is too early for the data to filter through in this year’s report, we would expect trade tensions with China and other trading partners to have a negative impact on the US’ competitiveness in the future, were they to continue,” Saadia Zahidi, the managing director at the World Economic Forum, said in an email.

“Open economies are more competitive.”

(Reporting by Katanga Johnson; Editing by Michelle Price)